NCT03898687View on ClinicalTrials.gov

The Use of Magtrace®/Sentimag® in Sentinel Node Biopsy for Malignant Melanoma. The Magmen Study.

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

March 1, 2019

Primary Completion Date

September 30, 2020

Study Completion Date

September 30, 2020

Conditions
MelanomaSentinel Lymph Node
Interventions
DEVICE

SLN Biopsy with Magtrace®/Sentimag®

Identification of SLN by means of Magtrace®/Sentimag® and SPIO-MRI

Trial Locations (1)

Unknown

Sahlgrenska University Hospital, Gothenburg

All Listed Sponsors
lead

Sahlgrenska University Hospital

OTHER

NCT03898687 - The Use of Magtrace®/Sentimag® in Sentinel Node Biopsy for Malignant Melanoma. The Magmen Study. | Biotech Hunter | Biotech Hunter